Quanticate announces Dr. Daniel Chapple as the company’s Vice President of Business Development and Marketing. Quanticate will leverage his business development leadership and extensive knowledge of the clinical CRO space, including full service CROs, specialist BPOs and solutions expertise in the pharmaceutical, biotechnology and medical device sectors.
“Daniel’s customer-focused orientation, self-awareness, and strong business acumen skills make him a good fit as part of our executive management team,” said David Underwood the Chairmen and CEO. “This is an exciting time at Quanticate as we are growing our operations in the US and India to support our teams already in place in the UK, Poland and South Africa. Daniel will help to streamline our approach to working across these regions to support our clients at the functional and task level due to his strong background.”Quanticate announces Dr. Daniel Chapple as the company’s Vice President of Business Development and Marketing.
The full press release can be found here.
I will say that I have reviewed three Clinical Study Reports (CSR) in the last two weeks [two CSRs were from other vendors] and this draft was by far the best one.
Telephone: +44 1462 440 084
Fax: +44 1462 440 086
Telephone: +1 617 973 5119
Fax: +1 617 973 6406